BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37588263)

  • 1. Transferrin-Conjugated PLGA Nanoparticles for Co-Delivery of Temozolomide and Bortezomib to Glioblastoma Cells.
    Ramalho MJ; Torres ID; Loureiro JA; Lima J; Pereira MC
    ACS Appl Nano Mater; 2023 Aug; 6(15):14191-14203. PubMed ID: 37588263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-
    Banstola A; Duwa R; Emami F; Jeong JH; Yook S
    Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy.
    Ramalho MJ; Serra É; Lima J; Loureiro JA; Pereira MC
    Eur J Pharm Biopharm; 2024 Jul; 200():114326. PubMed ID: 38759897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells.
    Ramalho MJ; Bravo M; Loureiro JA; Lima J; Pereira MC
    Life Sci; 2022 May; 296():120435. PubMed ID: 35247437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine.
    Ramalho MJ; Loureiro JA; Coelho MAN; Pereira MC
    Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31405159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy.
    Kadhim ZA; Sulaiman GM; Al-Shammari AM; Khan RA; Al Rugaie O; Mohammed HA
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic targeting of paclitaxel-loaded poly(lactic-
    Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
    Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells.
    Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC
    Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration.
    Wang S; Yu Y; Wang A; Duan X; Sun Y; Wang L; Chu L; Lv Y; Cui N; Fan X; Sha C; Xu L; Sun K
    Front Pharmacol; 2022; 13():965789. PubMed ID: 36059989
    [No Abstract]   [Full Text] [Related]  

  • 11. Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression.
    Zhu Z; Du S; Ding F; Guo S; Ying G; Yan Z
    Am J Transl Res; 2016; 8(7):3299-308. PubMed ID: 27508051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival.
    Rahman MA; Gras Navarro A; Brekke J; Engelsen A; Bindesbøll C; Sarowar S; Bahador M; Bifulco E; Goplen D; Waha A; Lie SA; Gjertsen BT; Selheim F; Enger PØ; Simonsen A; Chekenya M
    Br J Cancer; 2019 Oct; 121(7):545-555. PubMed ID: 31413318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth.
    Salzano G; Zappavigna S; Luce A; D'Onofrio N; Balestrieri ML; Grimaldi A; Lusa S; Ingrosso D; Artuso S; Porru M; Leonetti C; Caraglia M; De Rosa G
    J Biomed Nanotechnol; 2016 Apr; 12(4):811-30. PubMed ID: 27301207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells.
    Maliyakkal N; Appadath Beeran A; Udupa N
    Saudi Pharm J; 2021 Aug; 29(8):857-873. PubMed ID: 34408546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
    Yamada T; Tsuji S; Nakamura S; Egashira Y; Shimazawa M; Nakayama N; Yano H; Iwama T; Hara H
    J Neurosurg; 2020 Mar; 134(3):701-710. PubMed ID: 32168477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin Nanocage.
    Bouzinab K; Summers HS; Stevens MFG; Moody CJ; Thomas NR; Gershkovich P; Weston N; Ashford MB; Bradshaw TD; Turyanska L
    ACS Appl Mater Interfaces; 2020 Mar; 12(11):12609-12617. PubMed ID: 32073826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study.
    Rahman MA; Brekke J; Arnesen V; Hannisdal MH; Navarro AG; Waha A; Herfindal L; Rygh CB; Bratland E; Brandal P; Haasz J; Oltedal L; Miletic H; Lundervold A; Lie SA; Goplen D; Chekenya M
    Immun Inflamm Dis; 2020 Sep; 8(3):342-359. PubMed ID: 32578964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Efficacy of Temozolomide Loaded by a Tetrahedral Framework DNA Nanoparticle in the Therapy for Glioblastoma.
    Fu W; You C; Ma L; Li H; Ju Y; Guo X; Shi S; Zhang T; Zhou R; Lin Y
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39525-39533. PubMed ID: 31601097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.